Bank of Nova Scotia
BNS
Bank of Montreal
BMO
Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
CA Stock MarketDetailed Quotes
LABS MediPharm Labs Corp
- 0.065
- 0.0000.00%
15min DelayMarket Closed Dec 27 16:00 ET
26.72MMarket Cap-2.17P/E (TTM)
0.065High0.060Low127.97KVolume0.060Open0.065Pre Close7.82KTurnover0.10052wk High0.03%Turnover Ratio411.12MShares0.06052wk Low-0.03EPS TTM24.64MFloat Cap7.390Historical HighLossP/E (Static)379.07MShs Float0.055Historical Low-0.04EPS LYR7.69%Amplitude--Dividend TTM0.59P/B1Lot Size--Div YieldTTM
MediPharm Labs Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.20%9.8M | 8.00%10.35M | 67.23%9.77M | 49.49%33.06M | 62.59%9.13M | 17.12%8.51M | 119.69%9.58M | 19.81%5.84M | 1.87%22.12M | -2.21%5.62M |
| Operating revenue | 12.02%10.6M | 4.64%11.14M | 62.74%10.67M | 47.38%36.82M | 19.76%10.16M | 30.27%9.46M | 144.02%10.64M | 34.45%6.56M | 15.07%24.98M | 47.69%8.48M |
| Excise taxes | -16.34%799K | -25.73%788K | 26.05%900K | 31.09%3.76M | --1.03M | --955K | --1.06M | --714K | --2.87M | ---- |
| Cost of revenue | 9.69%6.68M | -20.58%6.93M | 30.50%7.12M | 13.22%27.21M | 28.31%6.94M | -27.97%6.09M | 78.34%8.73M | 3.33%5.46M | -34.98%24.03M | -49.56%5.41M |
| Gross profit | 29.09%3.12M | 299.77%3.42M | 585.01%2.65M | 405.90%5.86M | 940.76%2.2M | 303.11%2.42M | 260.71%855K | 196.03%387K | 87.45%-1.91M | 104.24%211K |
| Operating expense | -13.94%5.83M | -29.38%5.99M | 71.40%6.38M | -12.16%23.6M | 5.71%4.63M | -1.23%6.77M | -0.62%8.48M | -47.61%3.72M | -3.22%26.87M | -61.22%4.38M |
| Selling and administrative expenses | -14.10%5.48M | -26.33%5.93M | 78.76%6.5M | 0.16%24.8M | 24.67%6.74M | 19.05%6.38M | 17.04%8.05M | -48.96%3.63M | 7.48%24.76M | 27.28%5.4M |
| -Selling and marketing expense | -16.60%1.4M | -12.66%1.46M | -2.92%1.33M | 20.88%3.16M | 25.55%-1.55M | 1.45%1.68M | 7.34%1.67M | -8.31%1.37M | -43.53%2.62M | -247.24%-2.08M |
| -General and administrative expense | -13.21%4.08M | -29.90%4.48M | 128.12%5.17M | -2.29%21.64M | 10.70%8.29M | 26.89%4.7M | 19.86%6.38M | -59.75%2.27M | 20.32%22.14M | 164.39%7.49M |
| Research and development costs | 106.56%126K | -49.06%27K | 30.56%47K | -79.14%209K | -59.03%59K | -75.60%61K | -82.79%53K | -88.00%36K | -26.05%1M | -75.26%144K |
| Depreciation amortization depletion | ---- | ---- | ---- | -45.49%453K | ---- | ---- | ---- | ---- | -41.23%831K | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | -45.49%453K | ---- | ---- | ---- | ---- | -41.23%831K | ---- |
| Provision for doubtful accounts | ---- | ---- | ---- | -1,534.33%-1.92M | ---- | ---- | ---- | ---- | -98.03%134K | ---- |
| Other operating expenses | -32.74%226K | -91.32%33K | -434.00%-167K | -54.79%66K | 67.23%-700K | -73.14%336K | -71.85%380K | 115.67%50K | 103.02%146K | -21.99%-2.14M |
| Operating profit | 37.82%-2.71M | 66.27%-2.57M | -11.76%-3.73M | 38.34%-17.75M | 41.66%-2.43M | 45.87%-4.36M | 15.88%-7.63M | 55.58%-3.33M | 33.07%-28.78M | 74.38%-4.17M |
| Net non-operating interest income (expenses) | -364.00%-66K | -112.66%-10K | -53.47%114K | 6.03%475K | -38.54%126K | -78.45%25K | -2.47%79K | 432.61%245K | 104.36%448K | 105.00%205K |
| Non-operating interest income | -2.87%169K | 5.82%200K | -10.40%224K | 75.37%840K | 5.58%227K | 31.82%174K | 125.00%189K | 420.83%250K | 112.89%479K | 179.22%215K |
| Non-operating interest expense | 57.72%235K | 90.91%210K | 2,100.00%110K | 1,077.42%365K | 910.00%101K | 831.25%149K | 3,566.67%110K | 150.00%5K | -99.70%31K | 143.48%10K |
| Other net income (expenses) | 336.72%3.91M | 54.32%-756K | 466,800.00%4.67M | -18.24%-1.65M | 70.45%-1.66M | |||||
| Gain on sale of security | ---- | ---- | ---- | 38.38%-456K | ---- | ---- | ---- | ---- | -126.03%-740K | 45.44%-742K |
| Special income (charges) | --0 | --0 | ---- | 578.53%4.37M | 67.14%-300K | --0 | --4.67M | ---- | 78.47%-913K | ---913K |
| -Less:Restructuring and mergern&acquisition | --0 | --0 | ---- | ---4.67M | --0 | --0 | ---4.67M | ---- | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --183K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Write off | ---- | ---- | ---- | --40K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Gain on sale of business | ---- | ---- | ---- | 72.30%-251K | ---- | ---- | ---- | ---- | ---906K | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | 2,585.71%174K | ---- | ---- | ---- | ---- | ---7K | ---- |
| Income before tax | 35.94%-2.77M | 10.34%-2.58M | -16.94%-3.61M | 55.45%-13.36M | 45.50%-3.06M | 45.40%-4.33M | 67.94%-2.88M | 58.59%-3.09M | 45.16%-29.99M | 74.19%-5.62M |
| Income tax | 0 | -4,500.00%-276K | -4,450.00%-273K | -3K | -105.31%-6K | -185.71%-6K | ||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 35.89%-2.77M | 10.34%-2.58M | -16.94%-3.61M | 56.37%-13.08M | 50.31%-2.79M | 45.44%-4.33M | 67.94%-2.88M | 58.59%-3.09M | 45.29%-29.98M | 74.23%-5.61M |
| Net income continuous operations | 35.89%-2.77M | 10.34%-2.58M | -16.94%-3.61M | 56.37%-13.08M | 50.31%-2.79M | 45.44%-4.33M | 67.94%-2.88M | 58.59%-3.09M | 45.29%-29.98M | 74.23%-5.61M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 35.89%-2.77M | 10.34%-2.58M | -16.94%-3.61M | 56.37%-13.08M | 50.31%-2.79M | 45.44%-4.33M | 67.94%-2.88M | 58.59%-3.09M | 45.29%-29.98M | 74.23%-5.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 35.89%-2.77M | 10.34%-2.58M | -16.94%-3.61M | 56.37%-13.08M | 50.31%-2.79M | 45.44%-4.33M | 67.94%-2.88M | 58.59%-3.09M | 45.29%-29.98M | 74.23%-5.61M |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 63.64%-0.04 | 50.00%-0.01 | 66.67%-0.01 | 66.67%-0.01 | 66.67%-0.01 | 50.00%-0.11 | 75.00%-0.02 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 63.64%-0.04 | 50.00%-0.01 | 66.67%-0.01 | 66.67%-0.01 | 66.67%-0.01 | 50.00%-0.11 | 75.00%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending CA Stocks
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.